Ancestry (5)
- PC1 - Principal component 1 (phv00253598.v1.p1)
- PC2 - Principal component 2 (phv00253599.v1.p1)
- PC3 - Principal component 3 (phv00253600.v1.p1)
- PC4 - Principal component 4 (phv00253601.v1.p1)
- PC5 - Principal component 5 (phv00253602.v1.p1)
Demographics (1)
- SEX - Sex (phv00253591.v1.p1)
Other (13)
- AFFECTION_STATUS - Case control status of the subject (phv00253586.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00253595.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00253594.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00253585.v1.p1)
- COUNTRY - Subject country of origin (phv00253597.v1.p1)
- IS_TUMOR - Tumor status (phv00253596.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00253593.v1.p1)
- SAMPLE_ID - Sample ID (phv00253588.v1.p1)
- SAMPLE_USE - Sample Use (phv00253589.v1.p1)
- SLE - Systemic lupus erythematosus status (phv00253592.v1.p1)
- SUBJECT_ID - Unique subject ID (phv00253584.v1.p1)
- SUBJECT_ID - Unique subject ID (phv00253587.v1.p1)
- SUBJECT_ID - Unique subject ID (phv00253590.v1.p1)